Thursday, March 25, 2010 5:38:24 PM
NNVC SHORT ACTIVITY MARCH 2010
Date Shares Sold Short Total Volume Shorts as % of Vol.
3/1/2010 68007 185752 36.61%
3/2/2010 96595 266780 36.21%
3/3/2010 11888 67485 17.62%
3/4/2010 45460 109471 41.53%
3/5/2010 120620 437583 27.57%
3/8/2010 194510 498415 39.03%
3/9/2010 50200 198456 25.30%
3/10/2010 20836 71305 29.22%
3/11/2010 47530 81162 58.56%
3/12/2010 43620 104438 41.77%
3/15/2010 6300 40580 15.52%
3/16/2010 700241 2230084 31.40%
3/17/2010 547771 1525256 35.91%
3/18/2010 214348 550663 38.93%
3/19/2010 30515 213046 14.32%
3/22/2010 186656 408346 45.71%
3/23/2010 183340 454890 40.30%
3/24/2010 133053 407037 32.69%
3/25/2010 194905 401221 48.58%
Totals 2896395 8251970 35.10%
Looks to me like downward pressure tomorrow.
IMO.
m2m
Recent NNVC News
- NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • InvestorsHub NewsWire • 05/02/2024 02:07:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:30:41 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:44:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/01/2023 08:46:45 PM
- Clinical Trial of Broad-Spectrum Antiviral Drug NV-CoV-2 is Progressing Well, Says NanoViricides - NV-CoV-2 is Positioned to Fulfill Many Unmet Medical Needs • InvestorsHub NewsWire • 07/06/2023 03:16:37 PM
DaBaby and Stunna 4 Vegas's "NO DRIBBLE" Joins Music Licensing, Inc.'s Portfolio • SONGD • Jun 7, 2024 10:15 AM
Mushrooms Inc. (OTC: MSRM) Announces Significant Share Buy Back by the Board Director and New Strategic Initiatives. • MSRM • Jun 5, 2024 1:32 PM
Hydromer Announces Launch of HydroThrombX Medical Device Coating Technology • HYDI • Jun 5, 2024 10:24 AM
Dr. Michael Dent Finances $1 Million to Drive HealthLynked's Healthcare Transformation • HLYK • Jun 5, 2024 8:00 AM
Avant Technologies Enters Binding LOI to Purchase Dozens of High-Performance, Immersible, AI-Powered Servers • AVAI • Jun 5, 2024 8:00 AM
IQST - iQSTEL Announces $290 Million 2024 Annual Revenue Forecast • IQST • Jun 4, 2024 1:43 PM